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Volume 59, Number 6S Abstracts 35SResults: MM across VQI centers improved from 56%
in 2005 to 69% in 2009, and declined when many new cen-
ters joined VQI in 2010 (Fig). Longer center participation
in VQI was associated with improved MM across all proce-
dure types (Fig, B). After multivariable adjustment, centers
in VQI >2 years were 40% more likely to have patients on
MM (odds ratio, 1.4, 95% conﬁdence interval [CI], 1.4-
1.5; P < .01). Use of MM was associated with improved
2 year survival (92% vs 86%; HR for death, 0.6; 95% CI,
0.5-0.7; P < .01), as was treatment at centers in VQI >2
years (HR, 0.86; 95% CI, 0.8-0.9; P < .01).
Conclusions: These data demonstrate that optimal
MM is associated with improved survival after a number of
vascular procedures. Importantly, VQI participation improves
the use of MM, demonstrating that involvement in an orga-
nized quality effort can greatly impact patient outcomes.
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Objectives: To assess outcomes of retrograde emboli-
zation of arteriovenous malformations (AVM) with a
dominant outﬂow vein (DOV).
Methods: We retrospectively reviewed patients with
high ﬂow AVMs who were noted to have a DOV and sub-
sequently underwent transvenous embolization. Three
cases have been selected for video demonstration.
Results: FromNov 2010 to Sep 2013 11 patients (three
male [27%]) underwent transvenous embolization of high
ﬂow AVMs with a DOV. Mean age was 42.2 years (range,
16.4-65.8 years). The AVM was located on an extremity in
six patients (55%) and in the pelvis in ﬁve (45%). The indica-
tion for the procedure was pain in 10 patients (91%) and
swelling in two (18%). Transvenous embolization was per-
formed with coils in eight patients (73%) and with coils and
the Amplatzer Vascular Plug (St. Jude Medical, St. Paul,
Minn) in three (27%). Concurrent use of direct stick emboli-
zation of the AVMnidus was used in four patients (36%), and
transcatheter arterial embolization in seven (63%). Angio-
graphic success was seen in all patients. Five patients (45%)
required further procedures for residual symptoms.
Conclusions: AVMs with a DOV can be successfully
treated by a transvenous approach. The use of direct stick
embolization of the nidus and transcatheter arterial embo-
lization may assist in reducing ﬂow.
Technical description: Patient 1: We demonstrate the
use of retrograde transvenous embolization of an upper
extremity AVM, fed by branches from the proximal ulnar,
radial and common interosseous arteries. Coil embolization
of the vein was performed, followed by direct stick embo-
lization of the AVM nidus using nBCA adhesive. Patient 2:
An AVM involving shunting from the profunda artery to adysplastic draining vein was treated with coil embolization
of the vein, and transcatheter embolization of the profunda
branches using nBCA adhesive. Patient 3: A pelvic AVM
was treated using an Amplatzer Vascular Plug, coil embo-
lization of the outﬂow vein, and transcatheter arterial
embolization of the arterial branches.
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Objectives: A longstanding spirit of camaraderie has
existed between civilian and military surgeons in the US.
Volunteers from the Society for Vascular Surgery (SVS)
assisted active duty military surgeons in ﬁlling a critical
need for vascular surgery support in the evacuation of
injured U.S. soldiers. The objective of this study is to pro-
vide an assessment of this program, including character-
ization of workload and perspectives of participating
surgeons.
Methods: An online survey instrument (SurveyMon-
key), consisting of 34 questions, was developed and admin-
istered to participants (2003-2012) in the program. The
survey consisted of multiple choice and open-ended
questions.
Results: The response rate was 59% (68 of 115), with
84% indicating they had no prior military experience. The
majority of respondents (76%) served one tour, whereas
24% served multiple tours. The majority (65%) indicated
satisfaction in their operative workload, performing two
to ﬁve operations per week, whereas 17% performed six
to 10. Seventeen participated in clinical research during
the rotation, 70% of which resulted in scientiﬁc presenta-
tion or publication, or both. Over half participated in draft-
ing new Clinical Practice Guidelines for care of patients
with vascular injuries. Of respondents, 90% (n ¼ 61)
were satisﬁed or very satisﬁed with the experience and indi-
cated interest in continuing a civilian-military collabora-
tion. Most volunteers found great value in participating
ﬁrst hand with cutting-edge telemedicine and integration
of combat casualty care over a broad evacuation system
involving three continents.
Conclusions: Over a 10-year period of time civilian
vascular surgeons have provided critical open and endovascu-
lar care to injured U.S. soldiers. SVS volunteers were clinically
and academically active and found value in collaborating with
their military colleagues to provide an extremely high level of
combat casualty care. This unique collaboration carries on
historical traditions of our surgical heritage and is an
extremely valuable care model for future use.
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Objectives: To report early and late outcomes of
segmental resection and graft replacement of the inferior
vena cava (IVC) for malignant disease.
Methods: All patients who had IVC resection with
graft reconstruction from 1990 to 2013 were reviewed. Pa-
tients with tangential excision and primary or patch venor-
rhaphy were excluded. End points were early (<30 days)
mortality, major adverse events (MAE), graft-related com-
plications, primary patency, and recurrence-free and overall
survival.
Results: Among 2305 patients treated for retroperito-
neal malignancy, 102 (50% male; age, 56 6 15 years) had
IVC resection and graft replacement (prosthetic in 100).
Primary leiomyosarcoma occurred in 33 patients (32%)
and other malignancies in 69 (68%; P < .0001). Preopera-
tive performance status (Eastern Cooperative Oncology
Group) was good or excellent in 92 patients (90%). Resec-
tion of multiple IVC segments was required in 59 patients
(58%), 24 who needed renal vein reconstruction (24%) and
two who had hepatic vein reimplantation. One patient died
of intraoperative hemorrhage. Four others died #4
months, one procedure-related from duodenal leak and
multisystem organ failure. Fifteen patients had MAE
(15%), two graft-related. Over a mean follow-up of 56
months, seven patients had graft occlusion (6.9%). At 5-
years, overall survival was 51% (range, 1-214 months), local
recurrence-free survival was 66%, and disease-free survival
was 35%. Four patients underwent graft-related reinterven-
tions (4%). Kaplan-Meier estimates of IVC graft primary
patency were 95%, 92%, and 92% at 1, 3, and 5 years,
respectively.
Conclusions: IVC resection and graft replacement for
malignant disease is safe, durable and provides excellent
local control of the tumor in select patients.
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Objectives: Fenestrated and branched endografts
facilitate sealing in the visceral aorta to extend the landing
zone for complex aneurysms. We describe the causes and
implications of proximal endoleak in our experience.
Methods: All patients undergoing fenestrated/
branched repair were entered onto a prospective database.
Inclusion criteria necessitated the availability of at least one
postoperative contrast computed tomography scan. Three-
dimensional imaging was used to characterize morphology
and correlated with outcome. Blinded assessors resized the
repairs in the endoleak group to assess the change in prac-
tice from early repairs to current practice. Outcome mea-
sures were mortality and a composite of stent fracture,
type III and Ic endoleak, as an indicator of device stability.
Results: Up to July 2013, 969 patients underwent
fenestrated/branched repair. Emergency repairs (n ¼ 24)
and patients without requisite imaging (n ¼ 21) were
excluded, leaving 924 available for analysis. A type Ia endo-
leak was identiﬁed in 23 patients (2.5%). Landing zone
choice was implicated as cause of endoleak development,
because sealing in the visceral aorta was associated with endo-
leak development (52.2% vs 24.5%, P ¼ .006). Aortic-related
mortality was higher in the endoleak group, 30% vs 7%
respectively (P ¼ .001), and they experienced a higher inci-
dence of component instability, 34.8 vs 9.5% (P ¼ .001).
Conclusions: Fenestrated/branched endovascular
repair has a low incidence of sealing zone failure despite
the increased complexity. Choice of proximal landing
zone may predict occurrence of endoleak. Development
of a proximal endoleak seems to destabilize the repair
and may lead to increased mortality.
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Objectives: Endovascular aneurysm repair (EVAR)
has become the primary treatment for abdominal aortic
